Gossamer Bio (GOSS) Operating Leases (2019 - 2026)
Gossamer Bio (GOSS) posted quarterly Operating Leases of $4.2 million for Q1 2026, down 16.98% year-over-year from $5.0 million in Q1 2025, and up 20.52% quarter-over-quarter from $3.5 million in Q4 2025.
Gossamer Bio (GOSS) Operating Leases (2019 - 2026) Analysis & Trends
Gossamer Bio's Operating Leases history runs 8 years deep, the most recent figure standing at $4.2 million for Q1 2026.
- In Q1 2026, Operating Leases fell 16.98% year-over-year to $4.2 million; the TTM figure through Mar 2026 stood at $4.2 million (down 16.98% YoY), while the FY2025 annual figure was $3.5 million, down 21.33% from the prior year.
- Operating Leases for Q1 2026 stood at $4.2 million, up from $3.5 million in the prior quarter.
- The five-year high for Operating Leases was $7.8 million in Q2 2022, with the low at $144000.0 in Q4 2023.
- The 5-year median for Operating Leases is $4.3 million (2023), against an average of $4.4 million.
- The sharpest annual moves came in 2023 and 2024: Operating Leases slumped 95.82% in 2023, then jumped 2954.17% in 2024.
- Gossamer Bio's Operating Leases stood at $3.4 million in 2022, then plunged by 95.82% to $144000.0 in 2023, then surged by 2954.17% to $4.4 million in 2024, then retreated by 21.33% to $3.5 million in 2025, then advanced by 20.52% to $4.2 million in 2026.
- Business Quant data shows GOSS's Operating Leases at $4.2 million in Q1 2026, $3.5 million in Q4 2025, and $3.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Gossamer Bio | 50.34 Mn | -6.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.92 Mn |
| Mar 31, 2026 | 4.17 Mn |
| Dec 31, 2025 | 3.46 Mn |
| Sep 30, 2025 | 3.70 Mn |
| Jun 30, 2025 | 4.82 Mn |
| Mar 31, 2025 | 5.02 Mn |
| Dec 31, 2024 | 4.40 Mn |
| Sep 30, 2024 | 6.34 Mn |
| Mar 31, 2024 | 2.65 Mn |
| Dec 31, 2023 | 144,000.00 |
| Sep 30, 2023 | 4.21 Mn |
| Jun 30, 2023 | 1.83 Mn |
| Mar 31, 2023 | 5.71 Mn |
| Dec 31, 2022 | 3.45 Mn |
| Sep 30, 2022 | 7.12 Mn |
| Jun 30, 2022 | 7.80 Mn |
| Mar 31, 2022 | 5.71 Mn |
| Dec 31, 2021 | 3.22 Mn |
| Sep 30, 2021 | 3.96 Mn |
| Jun 30, 2021 | 6.17 Mn |